Abstract: A system that facilitates verifying insurance coverage of an insured includes a radio frequency identification (RFID) card, a card reader system, and an insurance system. The radio frequency identification card is coupled to a patient and is capable of transmitting card data. The card reader system receives the card data from the RFID card and transmits the card data via a communication platform. The insurance system receives the card data from the card reader system via the communication platform and determines whether the insured has insurance coverage based on the card data. The card reader system further transmits data on the type of service provided to the insured to the insurance system, which verifies whether the insured received service from a provider or the provider provided service to the insured based on the received service data from the card reader system.

Abstract: The invention features new helper virus-free methods for making herpesvirus amplicon particles that can be used in immunotherapies, including those for treating any number of infectious diseases and cancers (including chronic lymphocytic leukemia, other cancers in which blood cells become malignant, lymphomas (e.g. Hodgkin's lymphoma or non-Hodgkin's type lymphomas). Described herein are methods of making helper virus-free HSV amplicon particles; cells that contain those particles (e.g., packaging cell lines or patients' cells, infected in vivo or ex vivo); particles produced according to those methods; and methods of treating a patient with an hf-HSV particle made according to those methods.

Abstract: A process for forming a zeolite beta dielectric layer onto a substrate such as a silicon wafer has been developed. The zeolite beta is characterized in that it has a Si/Al of at least 25 and has crystallites from about 5 to about 40 nanometers. The process involves first dealuminating a starting zeolite beta, then preparing a slurry of the dealuminated zeolite beta followed by coating a substrate, e.g. silicon wafer with the slurry, heating to form a zeolite beta film and treating the zeolite beta with a silylating agent.

Abstract: The invention provides a method of compensating for crosstalk between electromagnetic sensors in an array, each sensor having a flux transformer with a current therein which does not vary smoothly with an applied magnetic field, each sensor configured to produce an output signal comprising a stepwise varying component and a finely varying component. The method comprises, for each sensor to be compensated, applying a crosstalk compensation function to the output signal of the sensor to be compensated, the crosstalk compensation function based at least in part on at least one of the stepwise and the finely varying components of at least one other of the sensors in the array.

Abstract: The invention features new helper virus-free methods for making herpesvirus amplicon particles that can be used in immunotherapies, including those for treating any number of infectious diseases and cancers (including chronic lymphocytic leukemia, other cancers in which blood cells become malignant, lymphomas (e.g. Hodgkin's lymphoma or non-Hodgkin's type lymphomas). Described herein are methods of making helper virus-free HSV amplicon particles; cells that contain those particles (e.g., packaging cell lines or patients'cells, infected in vivo or ex vivo); particles produced according to those methods; and methods of treating a patient with an hf-HSV particle made according to those methods.

Abstract: Disclosed are methods for inhibiting the side effects attendant treatment with HMG-CoA reductase inhibitors. Treatment of a patient with and HMG-CoA reductase inhibitor in combination with coenzyme Q.sub.10 provides a reduction in patient cholesterol levels and guards against typical HMG-CoA reductase-inhibitor side effects, most notably liver dysfunction and cardiac dysfunction. The combination of lovastatin, an HMG-CoA reductase inhibitor, and coenzyme Q.sub.10 in ratios of between 1:2 to 1:29 provide significant enhancement of a patient's caridac condition. By way of example, other HMG-CoA reductase inhibitors which may be included in the claimed combinations include pravastatin, compactin, fluvastatin, dalvastatin, simvastatin, BMY 22089, GR-95030, HR-780, CI-981, SQ 33,600, and BMY 22566 and XU-62-320.

Abstract: A collapsible tanning booth comprises at least two rear lamp units and at least two front lamp units, each of the units having a thin long casing that includes rear, side, top and bottom walls and a front panel, the front panel being of a material transmissive to ultraviolet light, a reflector panel adjacent the rear wall and lamps mounted between the reflector panel and the front panel. The rear lamp units are hinged together along their adjacent side walls so that they can be moved between a storage configuration in which they are substantially aligned transversely and a use configuration in which they are oblique transversely to each other.

Abstract: A method and system (28) are provided for dynamically controlling the content of a local receiver data base (24, 26) from a transmitter data base (20) in an information retrieval communication network (28) in which a message transmitter transmitting the transmitter data base (20) dynamically provides data base messages over a message distribution network (22) to local receivers receiving the local receiver data bases (24, 26). The transmitter data base (20) messages are used to incrementally increase and decrease the content of the local receiver data base (24, 26) on a record-by-record basis. In addition, non-data base messages may also be provided. The data base messages consist of displayable data as well as file maintenance messages. Storage templates (42) are retrievably stored at the local receiver data base (24, 26). These storage templates (42) are locally retrieved based on receipt of a unique identifier.